Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec 1;88(12):906-914.
doi: 10.1097/JCMA.0000000000001281. Epub 2025 Aug 15.

Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights

Affiliations
Review

Unraveling mitochondrial dysfunction in polycystic ovary syndrome: Pathophysiological insights

Chia-Jung Li et al. J Chin Med Assoc. .

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder that affects women of reproductive age. It is characterized by ovulatory dysfunction, excessive levels of androgens, and the presence of multiple cysts in the ovaries. Although the exact cause of PCOS remains uncertain, recent studies have identified mitochondrial dysfunction as a key contributing factor. Mitochondria, often described as the energy centers of the cell, are essential for producing ATP, generating reactive oxygen species (ROS), and regulating cell death pathways. A growing body of evidence shows that mitochondrial dysfunction occurs in the ovaries, skeletal muscle, and adipose tissue of individuals with PCOS. This dysfunction may play a central role in the development of the disorder by increasing oxidative stress and chronic inflammation, worsening insulin resistance, and interfering with oocyte growth and quality. This review summarizes recent progress in understanding how mitochondrial dysfunction contributes to the underlying biology of PCOS. It also explores emerging treatment strategies that aim to restore mitochondrial health, such as the use of antioxidants, therapies that specifically target mitochondria, and emerging mitochondrial replacement technologies. These approaches hold promise for reducing the symptoms and long-term complications associated with PCOS.

Keywords: Dysfunction; Mitochondria; Pathogenesis; Polycystic ovary syndrome; Reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: Dr. Kuan-Hao Tsui, an editorial board member at Journal of the Chinese Medical Association, had no role in the peer review process of or decision to publish this article. The other authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Schematic illustrating the link between PCOS and mitochondrial dysfunction. Mitochondria, essential for cellular energy production, are vulnerable to oxidative damage due to the proximity of mtDNA to ROS production sites and limited protective mechanisms. Excessive ROS accumulation induces mitochondrial damage, fission, and mtDNA instability, resulting in point mutations and DNA breaks. Impaired antioxidant enzyme activity exacerbates ROS accumulation, disrupting mitochondrial energy synthesis. Reduced OXPHOS activity further impairs cellular energy metabolism. Insulin also plays a key role in regulating mitochondrial function by influencing the electron transport chain and ATP production. mtDNA = mitochondrial DNA; OXPHOS = oxidative phosphorylation; PCOS = polycystic ovary syndrome; ROS = reactive oxygen species.

References

    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7. - PubMed
    1. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. ; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456–88. - PubMed
    1. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482–8. - PubMed
    1. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148:1145–59. - PMC - PubMed
    1. Pruett JE, Everman SJ, Hoang NH, Salau F, Taylor LC, Edwards KS, et al. Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition. Biol Sex Differ. 2022;13:45. - PMC - PubMed

Substances